GSK,Vir Biotechnology Win $1 Bln US Govt Contract For Covid Antibody Drug Sotrovimab

GlaxoSmithKline plc (GSK) and Vir Biotechnology, Inc. (VIR) on Wednesday said they securedd US government contract of about $1 billion to purchase their Covid-19 treatment, sotrovimab.

GSK is expected to supply these doses to the US government by December 17, 2021. Further, the government will have the option to purchase additional doses through March 2022.

The FDA had granted emergency use authorization for sotrovimab, an investigational monoclonal antibody for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients, in May 2021.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Starbucks has dropped its vaccine or weekly test requirement against Covid-19 for U.S. employees in the wake of last week's U.S. Supreme Court ruling. The court, in a 6-3 vote, has blocked President Joe Biden's vaccine-or-test mandate for private companies with 100 or more employees. However, it allowed the vaccine mandate to stand for certain health care workers. Mylan Pharmaceuticals Inc., affiliated to healthcare company Viatris Inc., is recalling one batch of its non-interchangeable Semglee (insulin glargine injection), 100 units/ml (U-100), 3mL prefilled pens due to the potential for a missing label, the U.S. Food and Drug Administration said. Mushie & Co, LLC is recalling FRIGG Silicone Pacifiers citing choking risk, the U.S. Consumer Product Safety Commission said. The recall involves about 333,725 units of FRIGG silicone pacifiers that came in two designs: Classic and Daisy. According to the agency, the base of the silicone nipple has a fine slit that can cause the nipple to detach from the plastic shield, posing a choking hazard.
Follow RTT